Rusoma Laboratories Pvt Ltd

Some wounds heal. Others stall for weeks, resisting every intervention.

Research now reveals why: certain bacteria colonising chronic wounds release toxic chemicals that overwhelm skin cells, effectively shutting down the body's repair process. Targeting this mechanism could restore healing where conventional wound care falls short.

In critical and post-surgical settings, where Rusoma's IV solutions support recovery, understanding infection pathways like these is essential to better patient outcomes.

Many centuries before the Christian Era, Sushruta's name was known across the world as a great surgeon, one who had successfully performed even cranial operations.

In the last decade of the 18th century, British surgeons witnessed two Vaidyas of Maharashtra performing plastic surgery with remarkable precision. The procedure was documented in detail with illustrations in a London publication in 1794. Based on this, British surgeon Dr. Karpue developed a method still acknowledged as the 'Indian method' of plastic surgery. As Dr. Gruthy observed, Indians were unparalleled in surgery, especially in laparotomy, lithotomy, and reconstructive procedures.

Rusoma carries this tradition of clinical precision into modern parenteral manufacturing, where every process reflects the same commitment to exactness.

Rusoma was the first pharmaceutical manufacturer to install a nitrogen generation plant with dual capability, converting to oxygen production during emergencies.

When COVID-19 created an unprecedented demand for medical oxygen, this infrastructure proved its worth. The ability to switch from nitrogen, used in routine manufacturing processes, to oxygen generation meant the facility could respond to a public health crisis without delay.

Preparedness is not about predicting the emergency. It is about building systems that adapt when one arrives.

A mother’s love is the first form of care we ever experience - gentle, selfless, and always healing. ❤️

This Mother’s Day, we celebrate every mother whose warmth and strength inspire care in its purest form.

To all the moms who heal hearts in countless ways every day - thank you. 🌸

Happy Mother’s Day from RUSOMA.

Asthma management has long focused on controlling symptoms. A new discovery could shift that approach entirely.

Researchers have identified a specific immune molecule that plays a central role in triggering airway inflammation. Targeting it effectively could lead to therapies that prevent asthma episodes at their source, not just manage them after they begin.

Root-cause treatment is the future of medicine. Rusoma's approach to parenteral therapy reflects the same principle: address the need at its core.

The Sushruta Samhita, written over 2,500 years ago, remains one of the most remarkable medical texts in history.

It catalogued more than 120 surgical instruments, described techniques for rhinoplasty and cataract extraction, and laid down structured guidelines for surgical training and hospital management. These contributions predated similar developments in Europe by centuries.

Rusoma draws strength from this lineage. The precision and discipline that defined ancient Indian surgery continue to inform how we approach pharmaceutical manufacturing today.

Two ports. Zero room for error.

Our PuraDrip Paracetamol Infusion I.P. bag is built around a dual port closure system. One port for the IV set with a twist-off protector, one for supplemental medication. Leak-proof, multi-spike ready, and designed to hold up when protocols get complex.

Because at the bedside, the bag should be the last thing slowing anyone down.

What if your bones could get stronger without a single step?

Researchers have identified Piezo1, a mechanosensory protein in bone cells that detects physical stress and triggers strengthening. This discovery could lead to therapies that replicate exercise's skeletal benefits for patients who are immobile, elderly, or at risk of osteoporosis.

Science continues to find new ways to support the body when it cannot support itself. Rusoma shares that commitment in parenteral therapy, delivering precision where patient care demands it.

Before the Hippocratic Oath became the cornerstone of Western medical ethics, a similar pledge existed in ancient India.

Ayurveda students entering formal training committed to honesty, discipline, and an unwavering dedication to the well-being of every patient. These vows were not symbolic. They were binding principles that governed clinical conduct and patient care.

Rusoma's work in parenteral therapy is rooted in the same belief: that medicine begins with a commitment to the person it serves.

Rusoma introduced IV fluid bags to India in 1979, long before the format became an industry standard.

More than four decades later, we remain one of only three manufacturers in the country producing IV fluids in flexible bag packaging. This format offers distinct advantages in safety, storage, and ease of administration over rigid containers.

Some firsts endure because they were built on the right foundation.